Warfield, Kelly L <br/><br/>
Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4.  [electronic resource] 

 -  Antiviral research  May 2016 
 - 93-98 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-9096 
<br/><br/><label>Standard No.: </label>10.1016/j.antiviral.2016.03.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>1-Deoxynojirimycin--administration & dosage<br/>Animals<br/>Antibodies, Viral--blood<br/>Antibody-Dependent Enhancement--drug effects<br/>Antiviral Agents--administration & dosage<br/>Cells, Cultured<br/>Chlorocebus aethiops<br/>Clinical Trials as Topic<br/>Dengue Virus--drug effects<br/>Disease Models, Animal<br/>Drugs, Investigational<br/>Endoplasmic Reticulum--drug effects<br/>Glycoside Hydrolase Inhibitors--administration & dosage<br/>Humans<br/>Inhibitory Concentration 50<br/>Mice<br/>Monocytes--virology<br/>Receptors, Interferon--deficiency<br/>Serogroup<br/>Severe Dengue--drug therapy<br/>Vero Cells<br/>alpha-Glucosidases--metabolism